Malasía - enska - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

oni global (malaysia) sdn bhd - zinc -

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

global therapeutics pty ltd - ascorbic acid,pyridoxine hydrochloride,sodium ascorbate,zinc glycinate -

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

global therapeutics pty ltd - ascorbic acid,pyridoxine hydrochloride,sodium ascorbate,zinc glycinate -

Nýja-Sjáland - enska - Ministry for Primary Industries

interchem agencies ltd - zinc sulphate monohydrate - zinc sulphate monohydrate 980 g/kg - oral nutrient/electrolyte

Tansanía - enska - Tanzania Medicinces & Medical Devices Authority

global dar es salaam pharmacy ltd, tanzania - zinc oxide plaster -

Tansanía - enska - Tanzania Medicinces & Medical Devices Authority

global dar es salaam pharmacy ltd, tanzania - zinc oxide plaster -

Tansanía - enska - Tanzania Medicinces & Medical Devices Authority

global dar es salaam pharmacy ltd, tanzania - zinc oxide plaster -

Tansanía - enska - Tanzania Medicinces & Medical Devices Authority

global dar es salaam pharmacy ltd, tanzania - zinc oxide plaster -

Tansanía - enska - Tanzania Medicinces & Medical Devices Authority

global dar es salaam pharmacy ltd, tanzania - zinc oxide plaster -

Bandaríkin - enska - NLM (National Library of Medicine)

watson laboratories, inc. - sertraline hydrochloride (unii: uti8907y6x) (sertraline - unii:quc7nx6wmb) - tablet - 25 mg - major depressive disorder –sertraline hydrochloride tablets are indicated for the treatment of major depressive disorder in adults. the efficacy of sertraline hydrochloride tablets in the treatment of a major depressive episode was established in six to eight week controlled trials of adult outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (seeclinical trials under clinical pharmacology ). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the antidepressant action of sertraline hydr